ObsEva SA

( )
OBSV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.17%144.680.7%$944.72m
PFEPfizer Inc. -0.58%35.790.9%$902.06m
MRKMerck & Co., Inc. 0.65%83.170.7%$696.87m
ABBVAbbVie, Inc. -1.41%85.911.9%$656.71m
BMYBristol-Myers Squibb Co. -1.25%58.251.0%$613.93m
LLYEli Lilly & Co. -0.55%148.991.1%$561.72m
AZNAstraZeneca Plc -2.68%54.171.2%$245.65m
NVSNovartis AG -1.32%86.300.2%$163.74m
GSKGlaxoSmithKline Plc -1.11%37.370.2%$104.98m
PRNBPrincipia Biopharma, Inc. 0.00%99.950.0%$80.20m
NVONovo Nordisk A/S -1.59%68.300.1%$57.05m
SNYSanofi 0.36%50.790.2%$49.34m
RGENRepligen Corp. -1.71%139.947.1%$47.54m
RPRXRoyalty Pharma Plc -3.71%40.230.2%$46.64m
OPKOPKO Health, Inc. 0.66%3.0711.2%$43.63m

Company Profile

ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland.